RASSF10 Is a TGFß-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer.

Richter, Antje M; Küster, Miriam M; Woods, Michelle L; Walesch, Sara K; Gökyildirim, Mira Y; Krueger, Marcus; Dammann, Reinhard H

Richter, Antje M; Küster, Miriam M; Woods, Michelle L; Walesch, Sara K; Gökyildirim, Mira Y; Krueger, Marcus; Dammann, Reinhard H.

Afiliación

Richter AM; Institute for Genetics, Justus-Liebig-University Giessen, 35452 Giessen, Germany.
Küster MM; Institute for Genetics, Justus-Liebig-University Giessen, 35452 Giessen, Germany.
Woods ML; Institute for Genetics, Justus-Liebig-University Giessen, 35452 Giessen, Germany.
Walesch SK; Institute for Genetics, Justus-Liebig-University Giessen, 35452 Giessen, Germany.
Gökyildirim MY; Institute for Genetics, Justus-Liebig-University Giessen, 35452 Giessen, Germany.
Krueger M; Institute for Genetics, University of Cologne, 50931 Köln, Germany.
Dammann RH; Institute for Genetics, Justus-Liebig-University Giessen, 35452 Giessen, Germany.

Cancers (Basel) ; 11(12)2019 Dec 08.

Article en En | MEDLINE | ID: mdl-31817988

Palabras clave

ASPP; E-cadherin; EMT; RASSF; TGFß; epigenetic; tumor suppressor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google